相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。From Molecular Mechanisms to Clinical Management of Antineoplastic Drug-Induced Cardiovascular Toxicity: A Translational Overview
Carlo Gabriele Tocchetti et al.
ANTIOXIDANTS & REDOX SIGNALING (2019)
Spinochrome D Attenuates Doxorubicin-Induced Cardiomyocyte Death via Improving Glutathione Metabolism and Attenuating Oxidative Stress
Chang Shin Yoon et al.
MARINE DRUGS (2019)
Nuclear magnetic resonance spectroscopy reveals metabolic changes in living cardiomyocytes after low doses of ionizing radiation
Michalina Gramatyka et al.
ACTA BIOCHIMICA POLONICA (2018)
Cardiac metabolism - A promising therapeutic target for heart failure
Hannah Noordali et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Timing of the negative effects of trastuzumab on cardiac mechanics after anthracycline chemotherapy
Christian Cadeddu et al.
INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING (2017)
Protective Effects of Dexrazoxane against Doxorubicin-Induced Cardiotoxicity: A Metabolomic Study
Yang QuanJun et al.
PLOS ONE (2017)
Effects of the kinase inhibitor sorafenib on heart, muscle, liver and plasma metabolism in vivo using non-targeted metabolomics analysis
Brian C. Jensen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Metabolite signatures of doxorubicin induced toxicity in human induced pluripotent stem cell-derived cardiomyocytes
Umesh Chaudhari et al.
AMINO ACIDS (2017)
Non-Targeted Metabolomics Analysis of the Effects of Tyrosine Kinase Inhibitors Sunitinib and Erlotinib on Heart, Muscle, Liver and Serum Metabolism In Vivo
Brian C. Jensen et al.
METABOLITES (2017)
Drugs that Affect Cardiac Metabolism: Focus on Perhexiline
Cher-Rin Chong et al.
CARDIOVASCULAR DRUGS AND THERAPY (2016)
Current views on anthracycline cardiotoxicity
Donato Mele et al.
HEART FAILURE REVIEWS (2016)
Early metabolomics changes in heart and plasma during chronic doxorubicin treatment in B6C3F1 mice
Laura K. Schnackenberg et al.
JOURNAL OF APPLIED TOXICOLOGY (2016)
Preventing antiblastic drug-related cardiomyopathy: old and new therapeutic strategies
Christian Cadeddu et al.
JOURNAL OF CARDIOVASCULAR MEDICINE (2016)
Novel insights in pathophysiology of antiblastic drugs-induced cardiotoxicity and cardioprotection
Martino Deidda et al.
JOURNAL OF CARDIOVASCULAR MEDICINE (2016)
Pathophysiology of cardiotoxicity induced by nonanthracycline chemotherapy
Clelia Madeddu et al.
JOURNAL OF CARDIOVASCULAR MEDICINE (2016)
Plasma metabolic profiling analysis of cyclophosphamide-induced cardiotoxicity using metabolomics coupled with UPLC/Q-TOF-MS and ROC curve
Jia Yin et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2016)
Cardioprotection by gene therapy A review paper on behalf of the Working Group on Drug Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology
Rosalinda Madonna et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)
Screening, Verification, and Optimization of Biomarkers for Early Prediction of Cardiotoxicity Based on Metabolomics
Yubo Li et al.
JOURNAL OF PROTEOME RESEARCH (2015)
Metabolomic approach to profile functional and metabolic changes in heart failure
Martino Deidda et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Modulation of fatty acid metabolism is involved in the alleviation of isoproterenol-induced rat heart failure by fenofibrate
Ping Li et al.
MOLECULAR MEDICINE REPORTS (2015)
Is AMPK the savior of the failing heart?
Ty T. Kim et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2015)
Mitochondrial oxidative metabolism and uncoupling proteins in the failing heart
Alexander T. Akhmedov et al.
HEART FAILURE REVIEWS (2015)
Metabolomics, a promising approach to translational research in cardiology
Martino Deidda et al.
IJC METABOLIC & ENDOCRINE (2015)
Effect of Inhibiting Malonyl-CoA Decarboxylase on Cardiac Remodeling after Myocardial Infarction in Rats
Hongquan Wu et al.
CARDIOLOGY (2014)
Oleuropein prevents doxorubicin-induced cardiomyopathy interfering with signaling molecules and cardiomyocyte metabolism
Ioanna Andreadou et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2014)
Targeting mitochondrial oxidative metabolism as an approach to treat heart failure
Natasha Fillmore et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)
HMDB 3.0-The Human Metabolome Database in 2013
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2013)
AMP-Activated Protein Kinase Regulation and Biological Actions in the Heart
Vlad G. Zaha et al.
CIRCULATION RESEARCH (2012)
Metabonomic study on the cumulative cardiotoxicity of a pirarubicin liposome powder
Wenjuan Cong et al.
TALANTA (2012)
Metabolomics as a tool for cardiac research
Julian L. Griffin et al.
NATURE REVIEWS CARDIOLOGY (2011)
Potential Biomarkers in Mouse Myocardium of Doxorubicin-Induced Cardiomyopathy: A Metabonomic Method and Its Application
Guangguo Tan et al.
PLOS ONE (2011)
Improvement of mechanical heart function by trimetazidine in db/db mice
Yuan-jing Li et al.
ACTA PHARMACOLOGICA SINICA (2010)
Metformin Prevents Progression of Heart Failure in Dogs Role of AMP-Activated Protein Kinase
Hideyuki Sasaki et al.
CIRCULATION (2009)
Activation of AMP-Activated Protein Kinase by Metformin Improves Left Ventricular Function and Survival in Heart Failure
Susheel Gundewar et al.
CIRCULATION RESEARCH (2009)
Metabolic modulation and cellular therapy of cardiac dysfunction and failure
Diana Revenco et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Metabonomic identification of novel biomarkers in doxorubicin cardiotoxicity and protective effect of the natural antioxidant oleuropein
Ioanna Andreadou et al.
NMR IN BIOMEDICINE (2009)
HMDB: a knowledgebase for the human metabolome
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2009)
NMR-based metabolic profiling and metabonomic approaches to problems in molecular toxicology
Muireann Coen et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2008)
Liquid chromatography and ultra-performance liquid chromatography-mass spectrometry fingerprinting of human urine - Sample stability under different handling and storage conditions for metabonomics studies
Helen G. Gika et al.
JOURNAL OF CHROMATOGRAPHY A (2008)
Early epirubicin-induced myocardial dysfunction revealed by serial tissue Doppler echocardiography:: Correlation with inflammatory and oxidative stress markers
Giuseppe Mercuro et al.
ONCOLOGIST (2007)
Chronic activation of peroxisome proliferator-activated receptor-α with fenofibrate prevents alterations in cardiac metabolic phenotype without changing the onset of decompensation in pacing-induced heart failure
Volodymyr Labinskyy et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Mechanisms of disease - The failing heart - An engine out of fuel
Stefan Neubauer
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Acute doxorubicin cardiotoxicity is successfully treated with the phytochemical oleuropein through suppression of oxidative and nitrosative stress
Ioanna Andreadou et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2007)
Discovery of potent and orally available malonyl- CoA decarboxylase inhibitors as cardioprotective agents
Jie-Fei Cheng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Transverse aortic constriction leads to accelerated heart failure in mice lacking PPAR-γ coactivator 1α
Zoltan Arany et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Centering, scaling, and transformations: improving the biological information content of metabolomics data
Robert A. van den Berg et al.
BMC GENOMICS (2006)
Metabolic manipulation in ischaemic heart disease, a novel approach to treatment
L Lee et al.
EUROPEAN HEART JOURNAL (2004)
Energy metabolism in heart failure
R Ventura-Clapier et al.
JOURNAL OF PHYSIOLOGY-LONDON (2004)
Moderate severity heart failure does not involve a downregulation of myocardial fatty acid oxidation
MP Chandler et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)
Uncoupling proteins in human heart
AJ Murray et al.
LANCET (2004)
Mechanisms for increased glycolysis in the hypertrophied rat heart
L Nascimben et al.
HYPERTENSION (2004)
Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with 31P-SLOOP magnetic resonance spectroscopy
M Beer et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Impaired myocardial fatty acid oxidation and reduced protein expression of retinoid X receptor-α in pacing-induced heart failure
JC Osorio et al.
CIRCULATION (2002)
Transcriptional activation of energy metabolic switches in the developing and hypertrophied heart
JJ Lehman et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2002)
Mitochondrial ATPase and high-energy phosphates in failing hearts
JB Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2001)
The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase
PF Kantor et al.
CIRCULATION RESEARCH (2000)
Mitochondrial respiratory chain activity in idiopathic dilated cardiomyopathy
AF Quigley et al.
JOURNAL OF CARDIAC FAILURE (2000)
The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes
RB Vega et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
分享论文
